On June 27, 2024, the bulk medicine tazobactam produced by The United Laboratories (Inner Mongolia) Co., Ltd. passed the technical review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration and was officially approved for marketing. This marks the company』s first fully chemically synthesized bulk medicine, enriching its bulk medicine portfolio and creating new growth opportunities for its bulk medicine business.